Canadian Cannabis Investor Resources

Did you know as an investor you can capitalize on the growth of legal cannabis in Canada through publicly-traded and private Licensed Producers? Keep track of the legal medical cannabis program overseen by Health Canada and the evolving framework for adult-use.


Aurora Cannabis is one of 26 licensed producers across Canada and the only one located in Alberta. Boasting the second highest square footage approved for production in Canada, Aurora was the first applicant in the Country to construct a purpose-built facility, which can now be described as no less than state-of-the-art. Because Alberta is one of the most business friendly provinces in the Country, Aurora is able to operate with lower overhead.


Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a medical marijuana company based out of Smiths Falls, Ontario. It is the first federally regulated, publicly traded cannabis producer in North America, traded on the Toronto Stock Exchange as CGC. Canopy Growth Corp. is the first multi-licensed, geographically diverse marijuana producer in Canada.


Emblem, a fully integrated Canadian healthcare and pharmaceutical company with the potential in a recreational marijuana market, to be generating $100 million in revenue, is led by a team of healthcare and Big Pharma executives, who have founded and run multi-billion dollar companies and have invested into the company.


Emerald Health Therapeutics, formerly T-Bird Pharma, Inc., is based in British Columbia and federally licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Emerald Health was the 8th company to be licensed by Health Canada and began trading publicly in 2015. Emerald Health, which wholly owns Emerald Botanicals, has a clear biotech focus and earned a federal research grant that allows it to investigate cannabis strains and new cultivation technologies.


OrganiGram, which has been shipping medical cannabis to patients since September 2014, is one of the more than thirty licensed producers across Canada and the only one located in New Brunswick. Its focus on certified organic cannabis separates it from other producers. A recent land acquisition has expanded its campus, allowing for capacity to produce up to 26mm grams upon completion by the spring of 2018 of a fully funded capital project.



As the 3rd LP backed by the same financial team that brought together OrganiGram and Emblem Cannabis, Green Organic Dutchman grows the highest quality Organic medical cannabis in small batches using craft growing, all natural and organic principles. With experienced, passionate growers with over 8 years of MMAR growing experience, 25 acres of land, and immediate revenue from wholesale market, Green Organic Dutchman expects to generate $90 million by 2018.


The way individuals access cannabis for medical purposes has changed. As of August 24, 2016, the Access to Cannabis for Medical Purposes Regulations (ACMPR) replaced the Marihuana for Medical Purposes Regulations (MMPR). Use the links found on this page to track rules, regulations and opportunities to capitalize on licensed producers of medical cannabis.

MMJ Quarterly Market Data
Marijuana for Medical Purposes

MMJ Quarterly Compliance and Enforcement Report
Inspection Data Summary

Latest News
Get The App

Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the latest breaking news and exclusives published.


ncv-news-ios-app-store

ncv-news-google-play

NCV Media, LLC

Thank you for reading

New Cannabis Ventures

Contributing original content and curating quality news on only the most promising cannabis companies and the most influential investors.

FOLLOW US ON